[go: up one dir, main page]

CN108852856A - Application of the Epigallo-catechin gallate (EGCG) in orthodontic art - Google Patents

Application of the Epigallo-catechin gallate (EGCG) in orthodontic art Download PDF

Info

Publication number
CN108852856A
CN108852856A CN201810943521.9A CN201810943521A CN108852856A CN 108852856 A CN108852856 A CN 108852856A CN 201810943521 A CN201810943521 A CN 201810943521A CN 108852856 A CN108852856 A CN 108852856A
Authority
CN
China
Prior art keywords
epigallo
egcg
art
orthodontic
catechin gallate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810943521.9A
Other languages
Chinese (zh)
Inventor
杨柳青
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liuzhou Peoples Hospital
Original Assignee
Liuzhou Peoples Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liuzhou Peoples Hospital filed Critical Liuzhou Peoples Hospital
Priority to CN201810943521.9A priority Critical patent/CN108852856A/en
Publication of CN108852856A publication Critical patent/CN108852856A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/60Preparations for dentistry comprising organic or organo-metallic additives
    • A61K6/69Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/30Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives

Landscapes

  • Health & Medical Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses a kind of application of Epigallo-catechin gallate (EGCG) in orthodontic art, it is related to pharmaceutical technology field, i.e. using Epigallo-catechin gallate (EGCG) as preventing the active constituent of tooth Demineralization to be added in the enamel adhesive of bracket used in orthodontic art, compared with prior art, Epigallo-catechin gallate (EGCG) is added in bonding agent used in bracket by the present invention in correction art, can effectively reduce bacterial plaque accumulation around fixed orthodontic patient's bracket and reduce hickie incidence.

Description

表没食子儿茶素没食子酸酯在牙齿正畸术中的应用Application of Epigallocatechin Gallate in Orthodontics

技术领域technical field

本发明涉及医药技术领域,尤其是一种表没食子儿茶素没食子酸酯在牙齿正畸术中的应用。The invention relates to the technical field of medicine, in particular to the application of epigallocatechin gallate in orthodontics.

背景技术Background technique

白斑(White spot lesion, WSL)是传统固定矫正常见的副作用,发病率为2%-96%,男性大于女性。白斑一般发生在唇面托槽周围,尤其表现为釉质表面细小的白色线条,严重时可伴发龋坏。白斑的微观表现是釉质脱矿,其发展迅速,在口腔卫生差的情况下,仅四周就可以观察到釉质表面脱矿,形成白斑。在传统正畸治疗过程中,需要在牙齿唇面粘接托槽。粘接托槽后,牙齿自洁作用降低,刷牙难度增大,托槽周围容易附着菌斑。以上原因都会导致牙齿表面细菌数量增多,尤其是变形链球菌和乳酸杆菌。这些细菌产酸导致釉质表面pH下降,发生脱矿,严重时会伴发牙齿表面龋坏。白斑产生的牙齿颜色改变会影响正畸术后效果,带来口腔美学问题,并且在正畸矫正器拆除后难以恢复。White spot lesion (WSL) is a common side effect of traditional fixed correction, with an incidence rate of 2%-96%, and men are more than women. Leukoplakia generally occurs around the lip brackets, especially as fine white lines on the surface of the enamel, and may be accompanied by caries in severe cases. The microscopic manifestation of leukoplakia is enamel demineralization, which develops rapidly, and in the case of poor oral hygiene, demineralization of the enamel surface can be observed in only four weeks to form leukoplakia. During traditional orthodontic treatment, brackets need to be bonded to the labial surface of the teeth. After bonding the brackets, the self-cleaning effect of the teeth is reduced, the difficulty of brushing teeth is increased, and plaque is easy to adhere around the brackets. The above reasons will lead to an increase in the number of bacteria on the tooth surface, especially Streptococcus mutans and Lactobacillus. The acid production of these bacteria leads to a decrease in the pH of the enamel surface, demineralization, and in severe cases, caries on the tooth surface. The change in tooth color caused by leukoplakia can affect the effect of orthodontic surgery, cause oral aesthetic problems, and it is difficult to recover after orthodontic appliances are removed.

从带环粘接到托槽粘接,正畸经历了革命性的发展,不同的粘接剂、粘接底板设计、酸蚀方法、粘接材料不断被研究、发展。目前,临床釉质粘接主要采用全酸蚀粘接系统。通过37%的磷酸酸蚀,在牙釉质表面形成凹坑状结构,其与树脂形成的微机械锁结提供粘接力。为了预防白斑的产生,目前,临床上采用的处理白斑的方法主要有预防方法主要有口腔卫生宣教,使用各种含氟产品、氯己定,控制酸蚀时间,应用含抗菌材料的树脂、玻璃离子改良的树脂粘接剂等。然而,个人口腔护理、使用含氟产品需要患者配合,使用含抗菌材料的树脂、玻璃离子改良的树脂粘接剂有一定临床效果,但白斑仍然是临床上常见的正畸并发症之一。因此,探索更有效的药物和预防方法仍然是现阶段的研究方向之一。From band bonding to bracket bonding, orthodontics has experienced revolutionary development. Different adhesives, bonding base designs, acid etching methods, and bonding materials have been continuously researched and developed. At present, the clinical enamel bonding mainly adopts the full-etch bonding system. Through 37% phosphoric acid etching, a pit-like structure is formed on the surface of the enamel, and the micromechanical lock formed with the resin provides adhesion. In order to prevent the occurrence of leukoplakia, at present, the methods used clinically to deal with leukoplakia mainly include preventive methods, mainly including oral hygiene education, using various fluorine-containing products, chlorhexidine, controlling acid etching time, and applying resin and glass containing antibacterial materials. Ion-improved resin adhesives, etc. However, personal oral care and the use of fluorine-containing products require the cooperation of patients. The use of resins containing antibacterial materials and glass ionomer-modified resin adhesives has certain clinical effects, but leukoplakia is still one of the common clinical orthodontic complications. Therefore, exploring more effective drugs and prevention methods is still one of the current research directions.

发明内容Contents of the invention

本发明所要解决的问题是提供一种表没食子儿茶素没食子酸酯在牙齿正畸术中的应用方案,这种应用方案能够有效降低临床正畸患者托槽周围脱矿、白斑的发生率。The problem to be solved by the present invention is to provide an application scheme of epigallocatechin gallate in orthodontics, which can effectively reduce the incidence of demineralization and leukoplakia around brackets in clinical orthodontic patients.

为了解决上述技术问题,本发明所采用的技术方案是:将表没食子儿茶素没食子酸酯作为防止牙齿脱矿作用的活性成分添加到牙齿正畸术中使用的托槽的釉质粘结剂中。In order to solve the above-mentioned technical problems, the technical solution adopted in the present invention is: adding epigallocatechin gallate as an active ingredient to prevent tooth demineralization into the enamel binder of the bracket used in orthodontics .

本发明的表没食子儿茶素没食子酸酯,是从绿茶中提取出的一种多酚类单体,具有抗菌、抗氧化、抗炎以及抗肿瘤等作用,且生物毒性低;它并不能直接杀死细菌,而是抑制了细菌脱氢酶活性,从而抑制细菌产酸过程,减少牙齿表面pH降低,达到防止釉质表面脱矿及龋坏的发生。Epigallocatechin gallate of the present invention is a kind of polyphenolic monomer extracted from green tea, has antibacterial, anti-oxidation, anti-inflammatory and anti-tumor effects, and low biological toxicity; it cannot directly Instead of killing bacteria, it inhibits the activity of bacterial dehydrogenase, thereby inhibiting the process of bacterial acid production, reducing the pH drop on the tooth surface, and preventing the demineralization of the enamel surface and the occurrence of caries.

由于采用了本发明技术方案,与现有技术相比,具有的有益效果是:本发明在牙齿正畸术中将表没食子儿茶素没食子酸酯添加到托槽所使用的粘接剂中,能够有效减少固定矫正患者托槽周围菌斑堆积以及降低白斑发生率。Due to the adoption of the technical solution of the present invention, compared with the prior art, the beneficial effect is: the present invention adds epigallocatechin gallate to the adhesive used in brackets in orthodontics, It can effectively reduce the accumulation of bacterial plaque around the brackets of fixed orthodontic patients and reduce the incidence of leukoplakia.

具体实施方式Detailed ways

以下结合具体实施例对本发明作进一步详述,但本发明的技术范围不受这些实施例限定。The present invention will be further described below in conjunction with specific examples, but the technical scope of the present invention is not limited by these examples.

患者选择:选择50位志愿者,根据随机原则将志愿者分为左半口实验组、右半口对照组或右半口实验组、左半口对照组,形成自身对照。Patient selection: 50 volunteers were selected, and according to the random principle, the volunteers were divided into left-half-mouth experimental group, right-half-mouth control group or right-half-mouth experimental group and left-half-mouth control group to form self-control.

试验方法:配制含2mg/ml的表没食子儿茶素没食子酸酯的粘接剂,实验组在粘接托槽过程中使用该粘接剂,对照组则使用不含表没食子儿茶素没食子酸酯的同一品牌粘接剂。实验开始前,对每位志愿者进行龈上洁治,去除口内牙结石等,将菌斑指数调整至同一基线。根据分组情况为每一位志愿者粘接托槽,粘接托槽时,注意刮净托槽周围多余树脂。除是否添加表没食子儿茶素没食子酸酯外,托槽品牌、粘接树脂、粘接剂等因素需完全一致,且所有步骤由同一位医生操作。托槽粘接完成后,对每位患者进行口腔卫生宣教,告知患者使用Bass刷牙法,以及分发统一品牌的牙刷牙膏。Test method: prepare an adhesive containing 2mg/ml epigallocatechin gallate, the experimental group uses the adhesive in the process of bonding brackets, and the control group uses no epigallocatechin gallate Ester adhesive of the same brand. Before the start of the experiment, supragingival cleaning was performed on each volunteer to remove dental calculus in the mouth, etc., and the plaque index was adjusted to the same baseline. According to the grouping situation, the brackets were bonded for each volunteer. When bonding the brackets, pay attention to scraping off the excess resin around the brackets. Except for the addition of epigallocatechin gallate, factors such as bracket brand, adhesive resin, and adhesive must be completely consistent, and all steps should be performed by the same doctor. After the bracket bonding was completed, oral hygiene education was given to each patient, and the patients were told to use the Bass method of brushing teeth, and a uniform brand of toothbrush and toothpaste was distributed.

检查方法和结果:Check method and result:

采用Quigley-Hein改良的Turesky菌斑指数判定前牙区菌斑指数和脱矿指数。在检查前去除患者口内弓丝和附件,嘱患者漱口,吹干,并根据下列标准进行记录:The Quigley-Hein modified Turesky plaque index was used to determine the plaque index and demineralization index of the anterior teeth. Remove the arch wire and accessories in the patient's mouth before the examination, instruct the patient to rinse and dry, and record according to the following criteria:

(1)脱矿指数:(1) Demineralization index:

0: 无脱矿,未见釉质龋白斑;0: no demineralization, no enamel caries leukoplakia;

1:轻度脱矿,可见白色脱矿区域,但釉质表面结构无破坏;1: Mild demineralization, white demineralized areas can be seen, but the surface structure of the enamel is not damaged;

2:中度脱矿,可见白色脱矿区域,且釉质表面粗糙,但不需要修复治疗;2: Moderate demineralization, white demineralized areas can be seen, and the enamel surface is rough, but no restorative treatment is required;

3:重度脱矿,可见白色脱矿区且釉质破坏,需要修复治疗;3: Severe demineralization, white demineralized areas can be seen and the enamel is damaged, and repair treatment is required;

4:龋洞。4: Cavities.

(2)菌斑指数:(2) Plaque index:

0:无菌斑;0: no plaque;

1:牙龈缘存在不连续的菌斑;1: There is discontinuous plaque on the gingival margin;

2:牙龈缘存在小于1mm的连续的菌斑;2: There is continuous plaque less than 1mm in the gingival margin;

3:牙面存在大于1mm但小于1/3 牙面的连续菌斑;3: There are continuous plaques larger than 1 mm but less than 1/3 of the tooth surface;

4:菌斑面积超过1/3但小于2/3;4: The plaque area exceeds 1/3 but less than 2/3;

5:菌斑面积超过2/3。5: The plaque area exceeds 2/3.

分别在4周、3个月、6个月、12个月时间段检查患者菌斑指数以及脱矿指数进行记录,结果见表1-表4: The plaque index and demineralization index of patients were checked and recorded at 4 weeks, 3 months, 6 months, and 12 months. The results are shown in Table 1-Table 4:

表1:菌斑及脱矿指数记录表(4周,平均值)Table 1: Plaque and demineralization index recording table (4 weeks, average value)

表2:菌斑及脱矿指数记录表(3个月,平均值)Table 2: Plaque and demineralization index recording table (3 months, average value)

表3:菌斑及脱矿指数记录表(6个月,平均值)Table 3: Plaque and demineralization index recording table (6 months, average value)

表4:菌斑及脱矿指数记录表(12个月,平均值)Table 4: Plaque and demineralization index recording table (12 months, average value)

由表1-表4的对比试验可以看出,比较实验组和对照组菌斑指数和脱矿指数具有显著差异。得出结论,在牙齿正畸术中,将表没食子儿茶素没食子酸酯添加到托槽使用的粘接剂中,能够有效减少固定矫正患者托槽周围菌斑堆积以及降低白斑发生率。As can be seen from the comparative tests in Table 1-Table 4, there are significant differences in plaque index and demineralization index between the experimental group and the control group. It is concluded that in orthodontics, adding epigallocatechin gallate to the adhesive used in brackets can effectively reduce the accumulation of plaque around the brackets and reduce the incidence of white spots in patients with fixed orthodontics.

Claims (1)

1. application of a kind of Epigallo-catechin gallate (EGCG) in orthodontic art, it is characterized in that by epi-nutgall catechu Plain gallate is as the enamel for preventing the active constituent of tooth Demineralization to be added to bracket used in clinic orthodontic art In binder.
CN201810943521.9A 2018-08-17 2018-08-17 Application of the Epigallo-catechin gallate (EGCG) in orthodontic art Pending CN108852856A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810943521.9A CN108852856A (en) 2018-08-17 2018-08-17 Application of the Epigallo-catechin gallate (EGCG) in orthodontic art

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810943521.9A CN108852856A (en) 2018-08-17 2018-08-17 Application of the Epigallo-catechin gallate (EGCG) in orthodontic art

Publications (1)

Publication Number Publication Date
CN108852856A true CN108852856A (en) 2018-11-23

Family

ID=64318227

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810943521.9A Pending CN108852856A (en) 2018-08-17 2018-08-17 Application of the Epigallo-catechin gallate (EGCG) in orthodontic art

Country Status (1)

Country Link
CN (1) CN108852856A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116747143A (en) * 2023-07-21 2023-09-15 首都医科大学附属北京口腔医院 Application of L-arginine in the preparation of orthodontic bonding compositions

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101674797A (en) * 2007-05-31 2010-03-17 学校法人日本大学 Adhesive for teeth-straightening members
CN101938985A (en) * 2008-02-08 2011-01-05 高露洁-棕榄公司 Compositions and devices
CN105342863A (en) * 2015-12-11 2016-02-24 张凌 Application of epigallocatechingallate (EGCG) in improving dental resin adhesive material restoration performance
CN105658633A (en) * 2013-09-03 2016-06-08 新加坡科技研究局 Polymer-flavonoid conjugates and hydrogels for biomedical applications

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101674797A (en) * 2007-05-31 2010-03-17 学校法人日本大学 Adhesive for teeth-straightening members
CN101938985A (en) * 2008-02-08 2011-01-05 高露洁-棕榄公司 Compositions and devices
CN105658633A (en) * 2013-09-03 2016-06-08 新加坡科技研究局 Polymer-flavonoid conjugates and hydrogels for biomedical applications
CN105342863A (en) * 2015-12-11 2016-02-24 张凌 Application of epigallocatechingallate (EGCG) in improving dental resin adhesive material restoration performance

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
(美)格莱伯等: "《正畸治疗中的风险管理》", 31 October 2010, 人民军医出版社 *
JIEQIONG HU等: "《Antibacterial and physical properties of EGCG-containing glass ionomer cements》", 《JOURNAL OF DENTISTRY》 *
XIJIN DU等: "《Epigallocatechin-3-gallate (EGCG) enhances the therapeutic》", 《JOURNAL OF DENTISTRY》 *
左艳萍等: "《实用口腔正畸矫治方法与技巧》", 28 February 2017, 科学技术文献出版 *
张丁: "《口腔正畸学的临床基础》", 29 February 2000, 中国医药科技出版社 *
林永旺等: "《表没食子儿茶素浸食子酸酯对脱矿釉质再矿化作用的体外研究》", 《牙体牙髓牙周病学杂志》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116747143A (en) * 2023-07-21 2023-09-15 首都医科大学附属北京口腔医院 Application of L-arginine in the preparation of orthodontic bonding compositions

Similar Documents

Publication Publication Date Title
Loguercio et al. A 36-month evaluation of self-etch and etch-and-rinse adhesives in noncarious cervical lesions
US5403577A (en) Dental composition for hypersensitive teeth
CN110996891B (en) Gel comprising chlorhexidine
Zabokova-Bilbilova et al. White spot lesions: prevention and management during the orthodontic treatment
US20050175959A1 (en) System for the controlled delivery of an active material to a dental site
US20130108982A1 (en) Reshapable Device for Fixation at a Dental Site
US9668844B2 (en) Device for fixation at a dental site
JP2002537003A (en) Dispensing system for oral care substances using a permanently deformable piece of material
Okida et al. The use of fragments of thin veneers as a restorative therapy for anterior teeth disharmony: a case report with 3 years of follow-up
TW201125489A (en) Biofilm disruptive compositions
Izgi et al. Direct restorative treatment of peg-shaped maxillary lateral incisors with resin composite: a clinical report
Lowder et al. Bond strength of 4 orthodontic adhesives used with a caries-protective resin sealant
Shim et al. Antiplaque and antigingivitis effects of a mouthrinse containing cetylpyridinium chloride, triclosan and dipotassium glycyrrhizinate
Scott et al. An update in adult orthodontics
JP6381912B2 (en) Oral composition
Metin-Gürsoy et al. The relationship between orthodontic treatment and dental caries
JP2020514354A5 (en)
Giuca et al. Oral manifestations in paediatric patients with hepatobiliary diseases: A review
Laing et al. An update on oral hygiene products and techniques
CN108852856A (en) Application of the Epigallo-catechin gallate (EGCG) in orthodontic art
JPH1149625A (en) Artificial tooth stabilizing agent composition
JPS59225109A (en) Composition for oral cavity application
Farzin et al. The effect of two types of denture adhesive on the satisfaction parameters of complete denture wearers
US20140271499A1 (en) Article and method of initiating bone regrowth and restoration of gum recession with localized subgingival delivery of medications
Isaeva et al. Efficacy of a Plant-Based Dental Gel for Chronic Simple Marginal Gingivitis: A Clinical Trial

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20181123